IL-22 increases proglucagon-expressing enteroendocrine cells via STAT3 in human iPSC-derived intestinal epithelium
Endocrinology · 2026
DOI: 10.1210/endocr/bqag101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2026. Verfasst von Yu Inoue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wellness Science Labs, Meiji Holdings Co., Ltd., Tokyo 192-0919, Japan. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Interleukins, Enteroendocrine Cells, Intestinal Mucosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Meiji Holdings Co., Ltd.
Abstract (Originalsprache)
Intestinal epithelial differentiation is tightly regulated to maintain tissue homeostasis and systemic metabolic function. Although the intrinsic transcriptional programs governing enteroendocrine cell (EEC) development have been characterized extensively, the role of extrinsic immune signals in directing lineage specification is not completely understood. In particular, how cytokine signaling influences differentiation of EEC subtypes remains unclear. Here, we investigated the role of interleukin-22 (IL-22) in EEC differentiation using human induced pluripotent stem cell-derived intestinal organoids and in vivo models. IL-22 selectively increased proglucagon (GCG) expression and the number of glucagon-like peptide-1 (GLP-1)-positive EECs without affecting other EEC markers. This effect was associated with enhanced expression of the lineage-related transcription factors neurogenin 3 and forkhead box A2. Pharmacological inhibition of signal transducer and activator of transcription 3 (STAT3) signaling attenuated the IL-22-induced increases in GCG expression and GLP-1-positive cell abundance, indicating a role of STAT3 in mediating these effects. Mechanistically, relatively high expression of IL-22 receptor subunit alpha 1 in undifferentiated epithelial cells was associated with STAT3 activation induced by IL-22. Consistent with these findings, in vivo IL-22 administration increased intestinal GCG expression and GLP-1 levels in the circulation and intestinal tissue. Importantly, our findings indicate that IL-22 does not globally promote EEC differentiation but rather selectively directs epithelial lineage commitment toward the GCG-positive EEC fate. These results suggest that IL-22/STAT3 signaling induces human intestinal epithelial differentiation into GCG-positive EECs and may represent a strategy for modulating epithelial cell fate to influence systemic metabolic homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellness Science Labs, Meiji Holdings Co., Ltd., Tokyo 192-0919, Japan.
ORCID-Profile: Hitoshi Watanabe
Förderung
- Meiji Holdings Co., Ltd
Zitieren
APA
Inoue, Y., Hattori, K., Hamaguchi, T., Sueki, Y., Wakabayashi, J., Funatsu, Y., & Watanabe, H. (2026). IL-22 increases proglucagon-expressing enteroendocrine cells via STAT3 in human iPSC-derived intestinal epithelium. Endocrinology. https://doi.org/10.1210/endocr/bqag101
Vancouver
Inoue Y, Hattori K, Hamaguchi T, Sueki Y, Wakabayashi J, Funatsu Y, et al. IL-22 increases proglucagon-expressing enteroendocrine cells via STAT3 in human iPSC-derived intestinal epithelium. Endocrinology. 2026. doi:10.1210/endocr/bqag101
BibTeX
@article{Inoue2026,
author = {Inoue, Yu and Hattori, Kouya and Hamaguchi, Takashige and Sueki, Yurina and Wakabayashi, Jun and Funatsu, Yui and Watanabe, Hitoshi},
title = {IL-22 increases proglucagon-expressing enteroendocrine cells via STAT3 in human iPSC-derived intestinal epithelium},
journal = {Endocrinology},
year = {2026},
doi = {10.1210/endocr/bqag101}
}
EUVIMED